Atomic IBD Newsletter
Atomic IBD is a health newsletter that mostly covers J&J, combination therapy in IBD and AbbVie. We've analyzed 2 issues from the past year; the latest was published Oct 31, 2026.
Main topics at a glance
Top 8 topics by mentions over the past year
2
Issues analyzed (12 mo)
28
Top topics
0
Brands mentioned
Oct 31, 2026
Latest issue
What Atomic IBD writes about
J&J
2 mentionscombination therapy in IBD
2 mentionsAbbVie
1 mentionsSpyre
1 mentionsco-formulation of antibodies
1 mentionsTARGET-CD
1 mentionsicotrokinra
1 mentionsemvistegrast
1 mentionsIBD polypill
1 mentionsDUET trial
1 mentionsVEGA trial
1 mentionsJNJ-4804
1 mentionsustekinumab and vedolizumab
1 mentionsobefazimod
1 mentionsHCXT-2001
1 mentionspairs of antibodies for IBD
1 mentionsEdinburghIBD.com
1 mentionsIcotyde
1 mentionsCOMBO-UC trial
1 mentionssubcutaneous infliximab plus ustekinumab
1 mentionstwo-in-one injection
1 mentionsupadacitinib
1 mentionsadvanced therapies given together
1 mentionsGilead
1 mentionszotemtegrast
1 mentionsoral IL-23 receptor peptide
1 mentionsoral α4β7
1 mentionsoral medicines
1 mentionsRecent issues of Atomic IBD
Explore more:Newsletter directory ·Trending Topics ·Weekly Insights